These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28322076)

  • 1. Closer than ever to an Ebola virus vaccine.
    Banadyga L; Marzi A
    Expert Rev Vaccines; 2017 May; 16(5):401-402. PubMed ID: 28322076
    [No Abstract]   [Full Text] [Related]  

  • 2. The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials.
    Suder E; Furuyama W; Feldmann H; Marzi A; de Wit E
    Hum Vaccin Immunother; 2018; 14(9):2107-2113. PubMed ID: 29757706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases.
    Tully CM; Lambe T; Gilbert SC; Hill AV
    Lancet Infect Dis; 2015 Mar; 15(3):356-9. PubMed ID: 25595637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial.
    Huttner A; Dayer JA; Yerly S; Combescure C; Auderset F; Desmeules J; Eickmann M; Finckh A; Goncalves AR; Hooper JW; Kaya G; Krähling V; Kwilas S; Lemaître B; Matthey A; Silvera P; Becker S; Fast PE; Moorthy V; Kieny MP; Kaiser L; Siegrist CA;
    Lancet Infect Dis; 2015 Oct; 15(10):1156-1166. PubMed ID: 26248510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Vesicular Stomatitis Virus-Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona.
    Marzi A; Hanley PW; Haddock E; Martellaro C; Kobinger G; Feldmann H
    J Infect Dis; 2016 Oct; 214(suppl 3):S360-S366. PubMed ID: 27496978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational success of fundamental virology: a VSV-vectored Ebola vaccine.
    Anderson EM; Coller B-AG
    J Virol; 2024 Mar; 98(3):e0162723. PubMed ID: 38305150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus.
    Mire CE; Geisbert JB; Marzi A; Agans KN; Feldmann H; Geisbert TW
    PLoS Negl Trop Dis; 2013; 7(12):e2600. PubMed ID: 24367715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ebola: Lessons on Vaccine Development.
    Feldmann H; Feldmann F; Marzi A
    Annu Rev Microbiol; 2018 Sep; 72():423-446. PubMed ID: 30200851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.
    Mwesigwa B; Houser KV; Hofstetter AR; Ortega-Villa AM; Naluyima P; Kiweewa F; Nakabuye I; Yamshchikov GV; Andrews C; O'Callahan M; Strom L; Schech S; Anne Eller L; Sondergaard EL; Scott PT; Amare MF; Modjarrad K; Wamala A; Tindikahwa A; Musingye E; Nanyondo J; Gaudinski MR; Gordon IJ; Holman LA; Saunders JG; Costner PJM; Mendoza FH; Happe M; Morgan P; Plummer SH; Hickman SP; Vazquez S; Murray T; Cordon J; Dulan CNM; Hunegnaw R; Basappa M; Padilla M; Gajjala SR; Swanson PA; Lin BC; Coates EE; Gall JG; McDermott AB; Koup RA; Mascola JR; Ploquin A; Sullivan NJ; Kibuuka H; Ake JA; Ledgerwood JE;
    Lancet Infect Dis; 2023 Dec; 23(12):1408-1417. PubMed ID: 37544326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ebola vaccines - Where are we?
    Watle SV; Norheim G; Røttingen JA
    Hum Vaccin Immunother; 2016 Oct; 12(10):2700-2703. PubMed ID: 27548643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent Advances in Vaccines and Drugs Against the Ebola Virus].
    Zhu X; Yao C; Wei Y; Kou Z; Hu K
    Bing Du Xue Bao; 2015 May; 31(3):287-92. PubMed ID: 26470536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection.
    Menicucci AR; Jankeel A; Feldmann H; Marzi A; Messaoudi I
    mBio; 2019 May; 10(3):. PubMed ID: 31138743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomonitoring of human responses to the rVSV-ZEBOV Ebola vaccine.
    Medaglini D; Siegrist CA
    Curr Opin Virol; 2017 Apr; 23():88-94. PubMed ID: 28460340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates.
    Marzi A; Engelmann F; Feldmann F; Haberthur K; Shupert WL; Brining D; Scott DP; Geisbert TW; Kawaoka Y; Katze MG; Feldmann H; Messaoudi I
    Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1893-8. PubMed ID: 23319647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know?
    Huttner A; Siegrist CA
    Expert Rev Vaccines; 2018 Dec; 17(12):1105-1110. PubMed ID: 30422031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term vaccine strategies for Ebola.
    Lauer KB; Faqih L; Blanchard TJ
    Lancet Infect Dis; 2015 May; 15(5):506-7. PubMed ID: 25932578
    [No Abstract]   [Full Text] [Related]  

  • 17. A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus.
    Tsuda Y; Caposio P; Parkins CJ; Botto S; Messaoudi I; Cicin-Sain L; Feldmann H; Jarvis MA
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1275. PubMed ID: 21858240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus.
    Mire CE; Matassov D; Geisbert JB; Latham TE; Agans KN; Xu R; Ota-Setlik A; Egan MA; Fenton KA; Clarke DK; Eldridge JH; Geisbert TW
    Nature; 2015 Apr; 520(7549):688-691. PubMed ID: 25853476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating Ebola vaccine trials: insights from simulation.
    Pulliam JRC; Bellan SE; Gambhir M; Meyers LA; Dushoff J
    Lancet Infect Dis; 2015 Oct; 15(10):1134. PubMed ID: 26461945
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine.
    Furuyama W; Shifflett K; Pinski AN; Griffin AJ; Feldmann F; Okumura A; Gourdine T; Jankeel A; Lovaglio J; Hanley PW; Thomas T; Clancy CS; Messaoudi I; O'Donnell KL; Marzi A
    mBio; 2022 Feb; 13(1):e0337921. PubMed ID: 35012339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.